Navigation Links


PharmTech in Medical News

Dong-A PharmTech Signs Licensing Deal With Otechestvennye to Market Zydena in Russia

SEOUL, South Korea, Oct. 15 /PRNewswire/ -- Dong-A PharmTech Co. Ltd announced today the signing of a five-year US$50 Million contract with Otechestvennye Lekarstva OJSC, to market in Russia Dong-A's erectile dysfunction drug which is currently sold in Korea under the brand name of Zydena. Un...

Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance

...se of $11.7 million, or 96.0%, compared with the prior year quarter. Included in the quarter ended March 31, 2009 was a $9.0 million payment to Dong-A pharmtech Co. Ltd. upon the achievement of a developmental milestone under our existing agreement for udenafil, an orally administered product for the treatment...

Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008

...th the prior year quarter. Included in R&D in the quarter ended December 31, 2008 was a $2.0 million expense to acquire certain rights from Dong-A pharmtech Co. Ltd. to develop and market its orally-administered udenafil product for the treatment of erectile dysfunction ("ED"). Excluding this $2.0 million ...

Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment

...ILTON, Bermuda, Jan. 6 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX ) today announced that it has signed an agreement with Dong-A pharmtech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatm...
PharmTech in Medical Technology

Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil

SEOUL, South Korea, Feb. 25 /PRNewswire/ -- Dong-A PharmTech Co., Ltd. announced today that its European licensee, Dr. Falk Pharma, has initiated a 200 patient, phase 2 proof of concept clinical study to investigate the use of udenafil, a long acting phosphodiesterase type 5 inhibitor, for por...

Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction

All Endpoints Met - Up to 88% Efficacy SEOUL, Korea, March 28, 2007 /PRNewswire/ -- Dong-A PharmTech Co., Ltd. announced today that it has completed a 340 patient phase 2b "at-home" clinical study for udenafil, its new long acting (12 hour half-life) oral phosphodiesterase type 5 (PDE5) inhibitor ...
Other TagsProtoProtoProtoProtoProtoProto
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center...as , is one of a growing number of physicians who ... sites to connect with individuals who are interes...bid obesity. Dr. Kim is utilizing Facebook to shar...s practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free na...az and Yasmin birth control pills who have suffere..., Stroke, Heart Attack or other related cardiac is...all toll free at 1-800-856-6405 or go to the firm&...ill out an online case evaluation form. , ...
(Date:11/25/2009)...VILLE, Calif., Nov. 25 ... announced that the company will host two investor... December 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ...resentations surrounding carfilzomib in relapsed a...the 51st American Society of Hematology (ASH) Annu...
(Date:11/25/2009)...ACH, Calif., Nov. 25 Thanksgiving ...ebound seniors in the greater Long Beach area than...a program operated by Independence at Home (IAH), ...ears these organizations have gathered hundreds of...seniors in need in Long Beach, Lakewood, Signal Hi...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
(Date:11/24/2009)...rescribed by traditional healers in Brazil to trea...ain to fever and flu. , Now for the first time, r...to scientifically prove the pain relieving propert...ian mint. , Testing this ancient South American h...ocha was able to show that when prepared as a ,tea...
(Date:11/24/2009)... arteries from collapsing have been true life-save...er needed -- once the arteries are strengthened, t... choice but to leave them in place. , Prof. Meit...f Biomedical Engineering has developed a new paten...they,re needed, then dissolves. , "Our new compo...
(Date:11/24/2009)...eld secrets of the earth,s history locked in its i... little information on the environments that have ...ears. Now, a team of researchers from nine institu... of $10 million dollars by the National Science Fo...literally. These scientists will drill through the...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Common Weight Loss Surgery May Double Risk of Kidney Stones 49638 1Common Weight Loss Surgery May Double Risk of Kidney Stones 49638 2MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang 21 49633 1MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang 21 49633 2DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 1DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 2
Other Contentstrialstrialstrialstrialstrialstrialsclinicalclinicalclinicalclinicalclinicalclinicalclinicalclinicalclinicalclinicalclitorisclitorisclotclotclotclotclotcobaltcobaltcobalamin